Schonfeld Strategic Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,624
| Closed | -$3.36M | – | 2162 |
|
|
2025
Q1 | $3.36M | Buy |
18,624
+11,020
| +145% | +$1.99M | 0.02% | 598 |
|
|
2024
Q4 | $1.19M | Buy |
7,604
+1,153
| +18% | +$181K | 0.01% | 983 |
|
|
2024
Q3 | $1.17M | Buy |
6,451
+581
| +10% | +$106K | 0.01% | 980 |
|
|
2024
Q2 | $1.08M | Buy |
5,870
+3,729
| +174% | +$685K | 0.01% | 1052 |
|
|
2024
Q1 | $381K | Sell |
2,141
-23,425
| -92% | -$4.17M | ﹤0.01% | 1384 |
|
|
2023
Q4 | $3.17M | Sell |
25,566
-58,069
| -69% | -$7.2M | 0.02% | 593 |
|
|
2023
Q3 | $9.7M | Buy |
83,635
+65,325
| +357% | +$7.58M | 0.08% | 318 |
|
|
2023
Q2 | $2.15M | Buy |
+18,310
| New | +$2.15M | 0.02% | 726 |
|
|
2022
Q4 | – | Sell |
-5,159
| Closed | -$359K | – | 2725 |
|
|
2022
Q3 | $359K | Buy |
+5,159
| New | +$359K | ﹤0.01% | 1937 |
|